Coriolis expands ATMP facilities to advance formulation 22-Jun-2021 By Ben Hargreaves Coriolis Pharma has announced a 7,800-meter-square expansion to a building situated in Munich, Germany, where the company is headquartered, that will host formulation development for advanced therapeutic medicine products (ATMPs).